Â鶹ŮÓÅ

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Medicaid Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • Â鶹ŮÓÅ Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • High Postcancer Medical Bills
  • Federal Workers’ Health Data
  • Cyberattacks on Hospitals
  • ‘Cheap’ Insurance

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Thursday, Jun 12 2025

Full Issue

Research Roundup: The Latest Science, Discoveries, And Breakthroughs

Each week, Â鶹ŮÓÅ Health News compiles a selection of the latest health research and news.

Using the progestogen-only contractive pill "desogestrel" for more than five years may increase the risk of developing a type of brain tumor known as an "intracranial meningioma," a new study has warned. The researchers noted that the risk is low—and is eliminated one year after desogestrel treatment is suspended—but that doctors' awareness of the possibility could eliminate the need for surgery in some cases. (Gray, 6/11)

Shorter leukocyte telomere length -- a marker of biological aging -- was tied to a higher risk of age-related brain disease, but modifiable risk factors appeared to mitigate its effect, U.K. Biobank data suggested. In a study of over 350,000 people, those with the shortest leukocyte telomeres had an elevated risk of subsequent dementia, stroke, or late-life depression compared with the longest telomeres, reported Christopher Anderson, MD, MMSc, of Mass General Brigham and Harvard Medical School in Boston, and colleagues. (George, 6/11)

Antibiotic exposure during pregnancy or early childhood is associated with increased risk of childhood atopic dermatitis (AD), according to a study published yesterday in eClinicalMedicine. In a review and meta-analysis, Chinese researchers examined 39 cohort studies involving expectant mothers and young children younger than 5 years old to explore the association between antibiotic exposure and the risk of childhood AD, a chronic skin condition characterized by inflammation, eczema-like lesions, and severe itching. (Dall, 6/11)

A new gene-tracking study in Nature shows that mpox spread among people in Nigeria for 8 years before it sparked a global outbreak in 2022. Using genomic tracing, researchers from Nigeria, the United States, Cameroon, Ethiopia, and Belgium estimate that the ancestor of the clade 2 mpox virus (mpxv) that ignited an international outbreak beginning in May 2022 first emerged in southern Nigeria in August 2014 and spread to 11 Nigerian states before human infections were detected in 2017. "We could have very easily prevented the 2022 multi-country outbreak if countries in Africa were given better access to therapeutics, vaccines, and surveillance technologies," one author said. (Wappes, 6/6)

When researchers at the University of California at San Francisco examined social media use and depressive symptoms among tweens over a three-year period, they found that an increase in social media use predicted a future rise in symptoms of depression — but not the other way around. The study, published in May in the American Medical Journal’s association journal JAMA, followed nearly 12,000 preteens over three years starting at age 9 to 10. (Gibson, 6/11)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, April 22
  • Tuesday, April 21
  • Monday, April 20
  • Friday, April 17
  • Thursday, April 16
  • Wednesday, April 15
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 Â鶹ŮÓÅ